Thomssen C - Search Results

1

ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019: Commentary by the German panel of experts on the ABC5 voting results.

Untch M, Würstlein R, Lüftner D, Haidinger R, Fasching PA, Augustin D, Briest S, Ettl J, Förster F, Kurbacher CM, Lück HJ, Marschner N, Müller L, Müller V, Radke I, Ruckhäberle E, Scheffen I, Schumacher-Wulf E, Schwoerer M, Steinfeld-Birg D, Ziegler-Löhr K, Thomssen C, Harbeck N. Untch M, et al. Among authors: thomssen c. Geburtshilfe Frauenheilkd. 2020 Jun;80(6):588-600. doi: 10.1055/a-1139-9380. Epub 2020 Jun 17. Geburtshilfe Frauenheilkd. 2020. PMID: 32565549 Free PMC article.

2

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Luck HJ, Thomssen C, duBois A, Lisboa BW, Untch M, Kuhnle H, Konecny G, Janicke F, Meerpohl HG, Lindner C, Hecker D, Diergarten K. Luck HJ, et al. Among authors: thomssen c. Semin Oncol. 1996 Feb;23(1 Suppl 1):33-6. Semin Oncol. 1996. PMID: 8629034 Clinical Trial.

3

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Lisboa BW, Untch M, Kühnle H, Jänicke F, Meerpohl HG, Lindner C, Konecny G, Hecker D, Diergarten K. Lück HJ, et al. Among authors: thomssen c. Semin Oncol. 1997 Feb;24(1 Suppl 3):S13-6. Semin Oncol. 1997. PMID: 9071334 Clinical Trial.

4

Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.

Lück HJ, Du Bois A, Thomssen C, Lisboa B, Untch M, Köhler G, Hecker D. Lück HJ, et al. Among authors: thomssen c. Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):34-7. Oncology (Williston Park). 1997. PMID: 9144689 Free article. Clinical Trial.

5

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer.

Schmitt M, Thomssen C, Ulm K, Seiderer A, Harbeck N, Höfler H, Jänicke F, Graeff H. Schmitt M, et al. Among authors: thomssen c. Br J Cancer. 1997;76(3):306-11. doi: 10.1038/bjc.1997.383. Br J Cancer. 1997. PMID: 9252196 Free PMC article.

6

Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K. Lück HJ, et al. Among authors: thomssen c. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-35-S17-39. Semin Oncol. 1997. PMID: 9374090 Clinical Trial.

7

Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin.

Lück HJ, Thomssen C, Du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K. Lück HJ, et al. Among authors: thomssen c. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):36-9. Oncology (Williston Park). 1998. PMID: 9516602 Free article.

8

Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.

Thomssen C, Oppelt P, Jänicke F, Ulm K, Harbeck N, Höfler H, Kuhn W, Graeff H, Schmitt M. Thomssen C, et al. Anticancer Res. 1998 May-Jun;18(3C):2173-80. Anticancer Res. 1998. PMID: 9703780

9

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

Jänicke F, Prechtl A, Thomssen C, Harbeck N, Meisner C, Untch M, Sweep CG, Selbmann HK, Graeff H, Schmitt M; German N0 Study Group. Jänicke F, et al. Among authors: thomssen c. J Natl Cancer Inst. 2001 Jun 20;93(12):913-20. doi: 10.1093/jnci/93.12.913. J Natl Cancer Inst. 2001. PMID: 11416112 Clinical Trial.

10

[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast].

Harbeck N, Thomssen C. Harbeck N, et al. Among authors: thomssen c. Zentralbl Gynakol. 2003 Sep;125(9):362-7. doi: 10.1055/s-2003-43036. Zentralbl Gynakol. 2003. PMID: 14569518 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters